Expression of the placental cytokines tumor necrosis factor α, interleukin 1β, and interleukin 10 is increased in preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 4, 1999, Pages 915-920

  Rinehart, Brian K ^a   Terrone, Dom A ^a   Lagoo Deenadayalan, Sandhya ^a   Barber, William H ^a   Hale, Enatra A ^a   Martin Jr , James N ^a   Bennett, William A ^a  

^a NONE

Author keywords

Cytokine expression; Placenta; Preeclampsia

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032722260     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70325-X     Document Type: Conference Paper

References (27)

1. 1. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-4.
2. 2. Roberts JM. Pregnancy-related hypertension. In: Creasy RK, Resnik R, editors. Pregnancy-related hypertension in maternal-fetal medicine. 4th ed. Philadelphia: WB Saunders; 1999. p. 841-4.
3. 3. Socol ML, Weiner CP, Louis G, Rehnberg K, Rossi EC. Platelet activation in preeclampsia. Am J Obstet Gynecol 1985;151: 494-7.
4. 4. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997;37:240-9.
5. 5. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990;70:427-51.
6. 6. Anderson JA, Miller FN, Sims DE, Edwards MJ. Tumor necrosis factor causes microvascular protein leakage independently of neutrophils or mast cells. J Surg Res 1994;56:485-90.
7. 7. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994;43: 1271-8.
8. 8. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Washington: The College; 1996. ACOG Technical Bulletin No.: 219.
9. 9. Bennett WA, Lagoo-Deenadayalan S, Brackin MN, Hale E, Cowan BD. Cytokine expression by models of human trophoblast assessed by a semiquantitative reverse transcription-polymerase chain reaction technique. Am J Reprod Immunol 1996;36:285-94.
10. 10. Taylor RN, Varma M, Teng NNH, Roberts JM. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 1990;71:1675-7.
11. 11. Taylor RN, Musci TJ, Rodgers GM, Roberts JM. Preeclamptic sera stimulate increased platelet-deviced growth factor mRNA and protein expression by cultural human endothelial cells. Am J Reprod Immuno 1991;25:105-8.
12. 12. Wilkins FC Jr, Alberola A, Mizelle HL, Opgenorth TJ, Granger JP. Systemic hemodynamics and renal function during long-term pathophysiological increases in circulating endothelin. Am J Physiol 1995;268:R375-81.
13. 13. Kahaleh MB, Fan PS. Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol 1997;15:163-7.
14. 14. Wang Y, Walsh SW. TNF-a concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 1996;32:157-69.
15. 15. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH. Tumor necrosis factor-alpha (TNF-a) gene polymorphism and expression in preeclampsia. Clin Exp Immunol 1996;104:154-9.
16. 16. Marcus BC, Hynes KL, Gewertz BL. Loss of endothelial barrier function requires neutrophil adhesion. Surgery 1997;122:420-6.
17. 17. Kupfermine MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socal ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994;170:1752-7.
18. 18. Kauma SW, Wang Y, Walsh SW. Preeclampsia is associated with decreased placental interleukin-6 production. J Soc Gynecol Invest 1995;2:614-7.
19. 19. Bennett WA, Lagoo-Deenadayalan S, Stopple JA, Barber WH, Hale E, Brackin MN, et al. Cytokine expression by first-trimester human chorionic villi. Am J Reprod Immunol 1998;10:309-18.
20. 20. Cadet P, Rady PL, Tyring SK, Yandell RB, Hughes TK. Interleukin-10 messenger RNA in human placenta: Implications for a role for interleukin-10 in fetal allograft protection. Am J Obstet Gynecol 1995;173:25-9.
21. 21. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon. Immunol Today 1993;14:353-7.
22. 22. Moore KW, O'Garra A, de Waal Malefyt R, Viera P, Mosmann TR. Interleukin-10. Ann Rev Immunol 1993;11:165-90.
23. 23. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
24. 24. Jaffe R, Jauniaux E, Hustin J. Maternal circulation in the first-trimester human placenta - myth or reality? Am J Obstet Gynecol 1997;176:695-705.
25. 25. Jauniaux E, Zaidi J, Jurkovic D, Campbell S, Hustin J. Comparison of colour Doppler features and pathological findings in complicated early pregnancy. Hum Reprod 1994;9:2432-7.
26. 26. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 1997;82:1582-8.
27. 27. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972;1:177-91.